Cafestol ameliorates diabetic nephropathy via Keap1-Nrf2 axis activation: A novel renoprotective mechanism independent of glycemic control
Nujud A Sinan, Mona S Almujaydil · 2026
Read Cafestol ameliorates diabetic nephropathy via Keap1-Nrf2 axis activation: A novel renoprotective mechanism independent of glycemic control by Nujud A Sinan, Mona S Almujaydil (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0349192.txt.
Description
Nujud A Sinan and Mona S Almujaydil tested whether cafestol, a compound from coffee, can protect kidneys in diabetic rats. Diabetes damages kidneys through inflammation, oxidation, and scarring, and current care slows rather than stops the decline. Rats made diabetic with a standard drug received cafestol by mouth for eight weeks at two doses. Other groups tested the compound alone and alongside a blocker of the pathway under study.
Cafestol eased nearly every sign of kidney injury in a dose-dependent way: less protein leaking into urine, calmer inflammation, restored antioxidant defences, and reduced tissue damage. The protection vanished when the blocker was added, pinpointing the mechanism as the switching-on of a master antioxidant controller in kidney cells. Healthy rats given cafestol showed no kidney harm. The authors present cafestol as a candidate protector worth further study.
Catalog record
| CREATOR | Nujud A Sinan, Mona S Almujaydil |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48581 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |